With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to ...

Medtronic announced today that it appointed Dr. Matthew Kroh as chief medical officer for Advanced and General Surgical Technologies.

Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...

A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected ... patients across all risk categories for an open surgical procedure, the same as in the U.S. FDA ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

The most recent quarter saw Medtronic increase its total revenue by 5.3% YoY. With its revenue sources spread relatively evenly among the Surgical, Neuroscience, and Cardiovascular segments with a ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...